We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Buy sub 9 / 9.2,in the build phase.
Silverhorse, how's the Polb day trading going? You change your stance more than a Liberal Democrat MP.
Good end of the day backs to double digits on the ask. We could well get end of year results tomorrow if last year is anything to go by. It would be nice to get a cherry on top with the results. We shall see.
Results are a bit late, i feel no news middle of april, it will likely slip back to 9p on small sells so let it happen
MaryB, is your crystal ๐ฎ ball telling you to buy or sell today? ๐ค
Not interested in anything that TW^T has to say, I think MaryB talks more sense using a crystal ๐ฎ ball, lol ๐
No sign of the TW podcast yet from the other day.
No,crystal ball, just observation and risk management.
Within the spread, sub 9 works, 9/9.2 can get 9.08, 9/9.3 can get 9.21 etc. Never tempted to buy above 11p, a trim atm. Trim over 11 unreleased news propelling.
That's how I roll here, not a recommendation.
Still see this as a trebler so aiming for 800k shares at 6p average and then phase 2 is reduce that position sub zero by a sell above 12p.
๐ฎ
Well done, but if everyone did that they would be no buyers at the top and no sellers at the bottom. Does your crystal ๐ฎ ball give the sell price and the buy price on a daily basis?
Buy large Q low, 70%+ sell higher. Rinse, repeat Working a treat. Have more here than intended and average settling around 7p & falling nicely ๐.
Large late reported buy ยฃ23k
Silverhorse, if it's hits 40p, I'm move to Cote d'Azur !!!! It's definitely possible ! Big news must be coming soon !!!! Sit tight and hold !
we seem to get a fair few sellers when it gets close to 10p - so many times it falls back but no so sure this time its holding up well, am so certain its going big one way or another so holding firm for 40p plus or if the **** hits the fan 2p
Yes delighted but unexpected. Thought today was going to be red waiting for news. No news but must be bubbling under
Mmm..sudden about turn from recent drift downwards...is something brewing or another false dawn? ๐ค
I think Poolbeg Pharma has become what was previously "Open Orphan" (before it aquired Hvivo) ๐ค as a lot of emphasis on Orphan Drug Development, if you carefully read the article from 'Who is Poolbeg Pharma?' A lot said about becoming 'Amryt Pharma 2' but definitely'Open Orphan' as well. Both positive I suppose. JMO Adyor!
Poolbeg Pharma specialises in the development of innovative medicines to address critical unmet medical needs.
This includes cancer immunotherapy-induced CRS, infectious diseases and metabolic conditions such as obesity with the development of an oral GLP-1R agonist.
The company is also placing a growing emphasis on rare and orphan diseases.
Poolbeg is focused on commercialising approved and marketed drugs to fund the development of future ground-breaking products in the immunotherapy space.
The notice of allowance from the US Patent Office for a #POLB 001 patent featured in @SmallCaps_UK
The claims cover the treatment & prevention of cytokine storm after an immune response has been triggered - in any disease indication
https://smallcaps.co.uk/poolbeg-pharma-closer-granting-patent-polb-001-treat-multiple-diseases/
Stop spouting more nonsense, I thought you were looking for 9p entry since you sold half your holdings in October. Make you mind up whether you ramping or not....
Alot of people follow him so would not be surprised to see this move up alot tomorrow, CF and tom will really blow this up - lets see
The guy is a complete tw^t
tom w (*************) is doing a podcast later today with cf. it will be interesting to hear when it is published.
gla.
NOPE ! No rise.
Closed period after director share purchase is well and truly over now so there will be no questions asked if any good news on partnership deals , mergers or acquisitions were to be announced. End of year results due shortly. We will see what we have left in the kitty, probably about a ยฃ10m cushion to carry us through to first revenues.
No. I hope you get your 9p buy in...